Psagot Investment House Ltd. Lowers Position in iShares Nasdaq Biotechnology ETF (IBB)

Psagot Investment House Ltd. lowered its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 14.2% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,962 shares of the financial services provider’s stock after selling 1,484 shares during the quarter. Psagot Investment House Ltd.’s holdings in iShares Nasdaq Biotechnology ETF were worth $1,002,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of IBB. Ellis Investment Partners LLC grew its stake in iShares Nasdaq Biotechnology ETF by 10,590.0% during the 1st quarter. Ellis Investment Partners LLC now owns 1,761,815 shares of the financial services provider’s stock worth $1,761,000 after purchasing an additional 1,745,334 shares in the last quarter. Deutsche Bank AG lifted its holdings in iShares Nasdaq Biotechnology ETF by 32,925.6% during the 4th quarter. Deutsche Bank AG now owns 1,683,314 shares of the financial services provider’s stock worth $162,320,000 after buying an additional 1,678,217 shares during the last quarter. State of Tennessee Treasury Department purchased a new stake in iShares Nasdaq Biotechnology ETF during the 4th quarter worth about $40,732,000. Lockheed Martin Investment Management Co. lifted its holdings in iShares Nasdaq Biotechnology ETF by 173.9% during the 4th quarter. Lockheed Martin Investment Management Co. now owns 417,400 shares of the financial services provider’s stock worth $40,250,000 after buying an additional 265,000 shares during the last quarter. Finally, Morgan Stanley lifted its holdings in iShares Nasdaq Biotechnology ETF by 3.7% during the 3rd quarter. Morgan Stanley now owns 4,026,110 shares of the financial services provider’s stock worth $490,944,000 after buying an additional 143,209 shares during the last quarter. Institutional investors own 67.92% of the company’s stock.

NASDAQ IBB traded up $0.33 during trading on Wednesday, reaching $104.68. 2,414,927 shares of the company’s stock were exchanged, compared to its average volume of 2,497,606. iShares Nasdaq Biotechnology ETF has a 1 year low of $89.01 and a 1 year high of $122.97.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by Sundance Herald and is owned by of Sundance Herald. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://sundanceherald.com/2019/05/22/psagot-investment-house-ltd-has-1-million-position-in-ishares-nasdaq-biotechnology-etf-ibb.html.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: How Do I Invest in Dividend Stocks

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply